AUR NHSN | Asolva

Asolva MEDICI®: First to Pass CDC Validation Test for Antimicrobial Resistance NHSN Reporting

by asolva | Jan 30, 2023

MEDICI®, Asolva’s antimicrobial stewardship software system, is the first software solution to have passed the CDC validation test for antimicrobial resistance (AR) reporting to the National Healthcare Safety Network (NHSN). Beginning in May 2023, hospitals can...

MEDICI Provides Enterprise-Wide Antimicrobial Use Reporting for Multi-Site Hospital System Linking Multiple EHRs

by asolva | Dec 19, 2020 | Uncategorized

Background Atrium Health, an integrated nonprofit health system, operating 42 hospitals, over 30 urgent care centers and more than 1,500 care locations in North Carolina and Georgia, needed a solution to measure hospital antibiotic use (AU) consistently across its...

Antimicrobial Use and Resistance (AUR) Module Definition

by asolva | Jan 1, 2018

https://www.cdc.gov/nhsn/PDFs/pscManual/11pscAURcurrent.pdf The NHSN AUR Module provides a mechanism for facilities to report and analyze antimicrobial use and/or resistance as part of local or regional efforts to reduce antimicrobial resistant infections through...